BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38410204)

  • 21. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Shi Y; Huang J; Hu Y; Shen Y
    BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral immune signature resembles tumor microenvironment and predicts clinical outcomes in head and neck squamous cell carcinoma.
    Hu Z; Zhou J; Li Y; Luan Y; Li H; Jia B; Xie Z; Cheng B; Wu T
    Front Immunol; 2022; 13():915207. PubMed ID: 36148222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
    Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
    Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma.
    Gao X; Zhao N; Dong L; Zheng X; Zhang Y; Ding C; Zhao S; Ma Z; Wang Y
    Front Oncol; 2021; 11():735993. PubMed ID: 34900686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory response-related genes predict prognosis in patients with HNSCC.
    Jing SL; Afshari K; Guo ZC
    Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of cuproptosis-related signature with the prognosis of patients with head and neck squamous cell carcinoma.
    Li Y; Sun C; Gu F; Yue J; Huang X; Yuan B; Wang Y; Chen R
    J Biomol Struct Dyn; 2024 Jan; ():1-12. PubMed ID: 38279934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an immune-related signature as a prognostic classifier for patients with early-stage head and neck squamous cell carcinoma.
    Wang L; Zhang Y; Li H; Peng J; Gao C; Yu Q; Gao P; Li L; Chen K; Ye F
    Transl Cancer Res; 2024 Mar; 13(3):1367-1381. PubMed ID: 38617526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation-sensitive genetic prognostic model identifies individuals at risk for radiation resistance in head and neck squamous cell carcinoma.
    You P; Liu S; Li Q; Xie D; Yao L; Guo C; Guo Z; Wang T; Qiu H; Guo Y; Li J; Zhou H
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15623-15640. PubMed ID: 37656244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
    Li Z; Shen L; Li Y; Shen L; Li N
    Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.
    Yang J; Xie K; Li C
    Life Sci; 2020 Sep; 256():117906. PubMed ID: 32504750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MTDH enhances radiosensitivity of head and neck squamous cell carcinoma by promoting ferroptosis based on a prognostic signature.
    Cao X; Ge Y; Yan Z; Hu X; Peng F; Zhang Y; He X; Zong D
    J Radiat Res; 2024 Jan; 65(1):10-27. PubMed ID: 37981296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma.
    Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C
    Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stemness-related lncRNAs signature as a biologic prognostic model for head and neck squamous cell carcinoma.
    Xu Z; Zhang M; Guo Z; Chen L; Yang X; Li X; Liang Q; Tang Y; Liu J
    Apoptosis; 2023 Jun; 28(5-6):860-880. PubMed ID: 36997733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomere maintenance genes-derived prognosis signature characterizes immune landscape and predicts prognosis of head and neck squamous cell carcinoma.
    Zou J; Chu S; Bao Q; Zhang Y
    Medicine (Baltimore); 2023 Aug; 102(31):e34586. PubMed ID: 37543795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma.
    He M; Wang L; Yue Z; Feng C; Dai G; Jiang J; Huang H; Ji Q; Zhou M; Li D; Chai W
    Aging (Albany NY); 2024 Jan; 16(2):1750-1766. PubMed ID: 38244579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
    Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
    Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.